Condition: Upper Respiratory Tract Infection · Prevention · Sponsor: Bioithas SL
Randomized, double-blind, placebo-controlled, parallel-group, clinical trial to assess the efficacy of the intake of a probiotic product composed of Lacticaseibacillus rhamnosus CRL1505 strain in reducing or preventing upper respiratory tract infections (URTIs) in a healthy paediatric population.
This description comes directly from the study's public registry record.
Juan Gabriel Agüera Santos · +34623022586 · juan.aguera@bioithas.com
Always discuss trial participation with your own doctor first.
| MiBioPath Research Group (UCAM) | Murcia, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07154992